EE03107B1 - Ravimpreparaat ja meetod selle valmistamiseks - Google Patents

Ravimpreparaat ja meetod selle valmistamiseks

Info

Publication number
EE03107B1
EE03107B1 EE9400134A EE9400134A EE03107B1 EE 03107 B1 EE03107 B1 EE 03107B1 EE 9400134 A EE9400134 A EE 9400134A EE 9400134 A EE9400134 A EE 9400134A EE 03107 B1 EE03107 B1 EE 03107B1
Authority
EE
Estonia
Prior art keywords
preparation
pharmaceutical
prepn
clodronate
dissolves
Prior art date
Application number
EE9400134A
Other languages
English (en)
Estonian (et)
Inventor
Posti Juhani
Katila Kirsti
Rantala Pertti
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of EE03107B1 publication Critical patent/EE03107B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EE9400134A 1992-04-24 1994-11-15 Ravimpreparaat ja meetod selle valmistamiseks EE03107B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201299A SE501389C2 (sv) 1992-04-24 1992-04-24 Farmaceutiskt preparat och förfarande för dess framställning

Publications (1)

Publication Number Publication Date
EE03107B1 true EE03107B1 (et) 1998-08-17

Family

ID=20386054

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400134A EE03107B1 (et) 1992-04-24 1994-11-15 Ravimpreparaat ja meetod selle valmistamiseks

Country Status (21)

Country Link
US (1) US5525354A (no)
EP (1) EP0637236B1 (no)
JP (1) JP3536106B2 (no)
AT (1) ATE143802T1 (no)
AU (1) AU671830B2 (no)
CA (1) CA2134196C (no)
CZ (1) CZ282871B6 (no)
DE (2) DE69305335T2 (no)
DK (1) DK0637236T3 (no)
EE (1) EE03107B1 (no)
ES (1) ES2094539T3 (no)
FI (1) FI110667B (no)
GR (1) GR3022249T3 (no)
HK (1) HK13097A (no)
HU (1) HU219342B (no)
IL (1) IL105403A (no)
NO (1) NO306654B1 (no)
RU (1) RU2116074C1 (no)
SE (1) SE501389C2 (no)
TW (1) TW273515B (no)
WO (1) WO1993021907A1 (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
HU220872B1 (en) 1993-05-15 2002-06-29 Roche Diagnostics Gmbh Tablets containing dichloromethylene diphosphonic acid as active agent with enhanced bioavailability and process for producing them
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
FI94926C (fi) * 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
US20010007863A1 (en) 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
FI98343C (fi) * 1995-03-21 1997-06-10 Orion Yhtymae Oy Peroraalinen formulaatio
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
JPH11137208A (ja) * 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
EP0998933A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
EP0998932A1 (de) * 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
EP1154761B1 (en) * 1999-02-22 2008-02-20 Merrion Research I Limited Solid oral dosage form containing an enhancer
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
US6410520B2 (en) 2000-02-01 2002-06-25 The Procter & Gamble Company Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
JP4489356B2 (ja) 2001-05-11 2010-06-23 メリオン リサーチ スリー リミテッド 浸透促進剤
AU4061702A (en) * 2001-05-15 2003-04-03 Mcneil-Ppc, Inc. Dip coating compositions containing starch or dextrin
US20030070584A1 (en) * 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US8309118B2 (en) * 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7429619B2 (en) * 2002-08-02 2008-09-30 Mcneil Consumer Healthcare Polyacrylic film forming compositions
US20080286359A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of risedronate
US7645459B2 (en) 2004-05-24 2010-01-12 The Procter & Gamble Company Dosage forms of bisphosphonates
US20080287400A1 (en) 2004-05-24 2008-11-20 Richard John Dansereau Low Dosage Forms Of Risedronate Or Its Salts
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
MX2008012678A (es) 2006-04-07 2008-12-17 Merrion Res Iii Ltd Forma de dosis oral solida que contiene un mejorador.
KR20110007242A (ko) 2008-05-07 2011-01-21 메리온 리서치 Ⅲ 리미티드 펩티드 조성물 및 그의 제조 방법
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
CN103476419A (zh) 2011-01-07 2013-12-25 梅里翁第三研究有限公司 口服投药的含铁药物组合物
ES2975708T3 (es) 2015-01-29 2024-07-12 Novo Nordisk As Comprimidos que comprenden agonista del GLP-1 y recubrimiento entérico

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
DE3767998D1 (de) * 1986-12-20 1991-03-14 Boehringer Mannheim Gmbh Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
JP2782691B2 (ja) * 1987-09-29 1998-08-06 ワーナー−ランバート・コンパニー 腸溶製剤の安定化
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique

Also Published As

Publication number Publication date
FI110667B (fi) 2003-03-14
HK13097A (en) 1997-02-14
WO1993021907A1 (en) 1993-11-11
FI944961A0 (fi) 1994-10-21
HU9403067D0 (en) 1994-12-28
EP0637236B1 (en) 1996-10-09
CA2134196C (en) 2004-02-10
IL105403A (en) 1998-03-10
HUT74572A (en) 1997-01-28
SE9201299D0 (sv) 1992-04-24
SE501389C2 (sv) 1995-01-30
FI944961A (fi) 1994-10-21
JP3536106B2 (ja) 2004-06-07
HU219342B (en) 2001-03-28
TW273515B (no) 1996-04-01
US5525354A (en) 1996-06-11
CZ282871B6 (cs) 1997-11-12
ES2094539T3 (es) 1997-01-16
SE9201299L (sv) 1993-10-25
ATE143802T1 (de) 1996-10-15
JPH07505898A (ja) 1995-06-29
DE637236T1 (de) 1995-07-06
RU94045950A (ru) 1996-11-10
DE69305335D1 (de) 1996-11-14
CA2134196A1 (en) 1993-11-11
GR3022249T3 (en) 1997-04-30
RU2116074C1 (ru) 1998-07-27
AU671830B2 (en) 1996-09-12
NO944001L (no) 1994-10-21
IL105403A0 (en) 1993-08-18
EP0637236A1 (en) 1995-02-08
NO944001D0 (no) 1994-10-21
DE69305335T2 (de) 1997-04-30
NO306654B1 (no) 1999-12-06
AU3955093A (en) 1993-11-29
DK0637236T3 (da) 1997-03-17
CZ261494A3 (en) 1995-02-15

Similar Documents

Publication Publication Date Title
EE03107B1 (et) Ravimpreparaat ja meetod selle valmistamiseks
FI950319A (fi) Säädellyn vapautumisnopeuden omaava morfiinivalmiste
ES2144077T3 (es) Formas de administracion que contienen sales solidas de acido r-tioctico con liberacion y biodisponibilidad mejoradas.
ES2062417T3 (es) Composiciones farmaceuticas de cimetidina.
FI960851A (fi) Menetelmä N-amino-1-hydroksi-alkylideeni-1,1-bisfosfonihappojen valmistamiseksi
ATE151285T1 (de) Orale arzneimittel mit kolonspezifischer freisetzung
BR9912066A (pt) Uso de um ingrediente ativo; método de tratamento de restenose; e; composição farmacêutica
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
SE9700885D0 (sv) New pharmaceutical formulation
ATE321538T1 (de) Orale darreichungsform für pyridin-2- ylmethylsulfinyl-1h-benzimidazole
MX9300330A (es) Composicion de recubrimiento de autodeposicion.
IT1285079B1 (it) Sistema attuatore per la compensazione dell'allineamento di una macchina.
NO944405L (no) Tablett med forbedret biologisk tilgjengelighet inneholdende diklormetylendifosfonsyre som aktiv forbindelse
CA2218643A1 (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
MX9200225A (es) Formulacion para verter destinada a la aplicacion de anthelminticos.
EP0824341A4 (en) PREVENTING TOOTH LOSS THROUGH ADMINISTRATION OF ALENDRONATE OR ITS SALTS
CA2057456A1 (en) Anti depression pharmaceutical
IS1881B (is) 2,4-dísúlfónýlfenýlbútýlnítrón, sölt þess, lyfjablanda ásamt notkun á þessu efnasambandi við framleiðslu á lyfi

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

MM4A Lapsed by not paying the annual fees

Effective date: 20091115